35.22
+2.00
+(6.02%)
As of 8:07:56 AM GMT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-3,207,000.00
-3,118,000.00
4,981,000.00
13,620,000.00
2,027,000.00
Investing Cash Flow
1,950,000.00
4,206,000.00
-5,176,000.00
-8,523,000.00
-1,672,000.00
Financing Cash Flow
-50,000.00
-1,377,000.00
-3,448,000.00
-873,000.00
2,033,000.00
End Cash Position
1,647,000.00
2,928,000.00
3,217,000.00
6,860,000.00
2,636,000.00
Income Tax Paid Supplemental Data
--
--
2,729,000.00
480,000.00
1,000.00
Interest Paid Supplemental Data
--
39,000.00
25,000.00
14,000.00
9,000.00
Capital Expenditure
-749,000.00
-707,000.00
-400,000.00
-284,000.00
-68,000.00
Issuance of Capital Stock
70,000.00
46,000.00
65,000.00
124,000.00
2,039,000.00
Repayment of Debt
--
--
--
-140,000.00
-6,215.00
Repurchase of Capital Stock
--
-1,153,000.00
-3,329,000.00
-857,000.00
--
Free Cash Flow
-3,956,000.00
-3,825,000.00
4,581,000.00
13,336,000.00
1,959,000.00
12/31/2020 - 9/14/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
609.SG ABIONYX Pharma SA
1.2060
-2.11%
SAR.L Sareum Holdings plc
21.56
-2.02%
POLB.L Poolbeg Pharma PLC
4.8375
-1.48%
VERA Vera Therapeutics, Inc.
34.77
-6.08%
APGE Apogee Therapeutics, Inc.
40.91
-0.34%
CRNX Crinetics Pharmaceuticals, Inc.
38.98
-3.97%
APLS Apellis Pharmaceuticals, Inc.
28.59
+4.19%
CDT Conduit Pharmaceuticals Inc.
0.0932
-24.41%
BNTX BioNTech SE
113.74
-7.42%
HOTH Hoth Therapeutics, Inc.
1.8900
-0.53%